Mochi Health vs Sequence Weight Loss: Obesity Specialist vs Insurance Navigation
An independent, side-by-side comparison of Mochi Health and Sequence for GLP-1 weight loss programs — pricing, medications, protocols, and patient experience.
Quick Verdict
Best Price
Sequence
Starting at $99/mo vs $149/mo
Most Medications
Mochi Health
2 medications vs 2
Best for Beginners
Mochi Health
Hybrid, fast onboarding
Head-to-Head Comparison
Pricing Breakdown
Side-by-side pricing for every medication.
| Medication | Mochi Health | Sequence | Savings |
|---|---|---|---|
| Semaglutide | $149/monthly | $99/monthly | Save $50/mo with Sequence |
| Tirzepatide | Not offered | Not offered | Only at Sequence |
Pros and Cons
Mochi Health
- Video consultations with board-certified obesity medicine providers
- Registered dietitian access included in membership
- Orforglipron (oral GLP-1) available at $149/mo
- Brand-name injectable GLP-1s available through insurance, plus non-GLP-1 alternatives
- Insurance support with prior authorization handling
- Available in 49 states
- Membership fee is required on top of medication cost
- Lab work not included (recommended but at additional cost)
- Some patients have reported shipping delays
- Early-stage company with limited funding (~$1M raised) compared to established players
- Compounded GLP-1 options permanently unavailable
- Not available in Alabama
Sequence
- Founded by obesity medicine specialists
- Insurance-first approach can save patients hundreds per month on brand-name GLP-1 medications
- Video consultations with experienced clinicians, not just questionnaire-based async reviews
- Prior authorization and insurance appeals support included in membership
- Personalized titration managed through follow-up video visits
- Higher total cost for cash-pay patients
- The $99/month membership is charged on top of medication costs (unlike all-inclusive platforms)
- No published independent outcomes data for their patient population
- Insurance navigation success varies
- Less established brand than Hims or Ro
How They Compare
Our editorial assessment across key dimensions.
In-Depth Comparison
By sarah-chen · Last updated April 15, 2026
Mochi Health vs Sequence Weight Loss (2026)
Mochi Health and Sequence address different bottlenecks in GLP-1 access. Mochi solves the clinical depth problem — providing board-certified obesity medicine specialists for patients who need expert medical management. Sequence solves the affordability problem — navigating insurance coverage for patients who need brand-name GLP-1 at a lower cost. The best choice depends on which problem is most limiting for you.
Quick Comparison
| Mochi Health | Sequence (via Noom) | |
|---|---|---|
| Monthly cost | ~$149–299/month | ~$99/month + copays |
| Prescriber credential | Board-certified obesity medicine (ABOM) | Mixed specialties |
| Insurance navigation | Yes — insurance team | Yes — core specialty |
| GLP-1 prescription | Yes | Yes |
| Non-GLP-1 medications | Yes (limited) | Limited |
| Coaching | Obesity medicine + dietitian coaching | Health coach + dietitian access |
| Body composition tracking | Emphasized | Weight tracking primarily |
| Lab review | Included | Included |
| Program commitment | Ongoing subscription | Month-to-month |
The Core Distinction
Mochi's differentiator is who prescribes: Board-certified obesity medicine physicians have completed additional training specifically in obesity pharmacotherapy, body composition, metabolic medicine, and the behavioral-biological intersection of chronic weight management. This certification (ABOM — American Board of Obesity Medicine) is held by fewer than 7,000 physicians nationally.
Sequence's differentiator is getting paid: Sequence's insurance navigation team knows which commercial insurers cover which GLP-1 medications under what criteria, how to document prior authorization requests that get approved, and how to appeal denials. For patients with commercial insurance, this expertise can mean the difference between $900/month cash-pay and $40–80/month copay.
Who Gets the Most Value from Each
Mochi Health is best for patients who:
- Have already navigated prior programs and want specialist-level clinical evaluation
- Have complex metabolic profiles: T2D + PCOS + sleep apnea + prior GLP-1 non-response
- Want comprehensive body composition assessment alongside weight management
- Need multi-medication approaches and want expert guidance
- Don't have insurance coverage (cash-pay) and want the best clinical management
Sequence is best for patients who:
- Have commercial insurance where GLP-1 coverage may be accessible
- Have had prior authorization denied and want specialist appeal support
- Have employer benefits that may include GLP-1 coverage they haven't accessed
- Are primarily seeking brand-name semaglutide or tirzepatide at insurance pricing
- Want the structured behavioral curriculum (Noom) alongside medical prescribing
Insurance Navigation: The Numbers
For patients with commercial insurance and appropriate BMI + comorbidities:
| Scenario | Mochi (Annual) | Sequence (Annual) |
|---|---|---|
| GLP-1 covered, $40/month copay | ~$1,788–3,588 + $480 = $2,268–4,068 | ~$1,188 + $480 = $1,668 |
| GLP-1 denied, cash-pay compounded | ~$1,788 + $1,800 = $3,588 | ~$1,188 + $1,800 = $2,988 |
| GLP-1 denied, appeals succeed via Sequence | N/A (Mochi can appeal) | ~$1,188 + $480 = $1,668 (savings are substantial) |
If Sequence's specialized navigation unlocks covered GLP-1, the annual savings vs cash-pay can exceed $10,000 (brand-name GLP-1 at copay vs MSRP). Even vs Mochi's insurance team, Sequence's deeper expertise increases approval probability.
Clinical Depth vs Insurance Access: A Decision Framework
| Patient Profile | Recommendation | Reason |
|---|---|---|
| Complex obesity history, multiple failed programs | Mochi | Board-certified specialist for complexity |
| Commercial insurance, GLP-1 may be coverable | Sequence | Insurance navigation specialty |
| No insurance, cash-pay, simple case | Lower-cost option (Henry Meds, Medvi) | Neither Mochi's specialist cost nor Sequence's insurance value applies |
| Complex case AND commercial insurance | Mochi (insurance nav as secondary feature) | Specialist need outweighs insurance specialization |
| Simple case AND need insurance help | Sequence | Insurance nav is primary value |
| T2D + PCOS + severe obesity | Mochi | Multi-system complexity needs specialist |
Pricing Compared
| Plan | Mochi | Sequence |
|---|---|---|
| Monthly fee | ~$149–299 | ~$99 |
| Annual fee range | ~$1,788–3,588 | ~$1,188 |
| Medication (if cash-pay) | ~$1,800 (compounded) | ~$1,800 (compounded) or ~$480 (insured) |
Mochi's higher monthly fee reflects specialist care delivery. Sequence's lower fee reflects its subscription model, with value created through insurance navigation rather than clinical intensity.
Related Resources
- Mochi Health Review — full program review
- Sequence Weight Loss Review — full review
- Mochi Health vs Calibrate — similar specialist vs insurance comparison
- Found vs Sequence — multi-medication vs insurance specialist
- GLP-1 Insurance Denial FAQ — how to navigate and appeal denials
Related Guides
Best Telehealth Providers for Tirzepatide 2026: Ranked by Price and Care
The best telehealth providers for tirzepatide in 2026, ranked by price, protocol, and care quality. From $278/month compounded to brand Zepbound via insurance. No provider paid for placement.
Read guide →Is Compounded Semaglutide Legal and Safe in 2026?
Is compounded semaglutide still legal? We break down the current FDA rules, 30 new warning letters, SAFE Drugs Act, Hims exiting compounded, and what this means for your prescription.
Read guide →Compounded Tirzepatide 2026: What's Happening and What Patients Should Do
Compounded tirzepatide is under active FDA enforcement as of March 2026 — supply is declining but not yet at zero. The 503B enforcement discretion ended over a year ago (March 2025); the FDA has now issued 50+ warning letters including a 30-letter batch in March 2026. Here's what patients need to know and what to do.
Read guide →